Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice

References

• Avraham Y, Grigoriadis N, Poutahidis T, Vorobiev L, Magen I, Ilan Y, Mechoulam R, Berry E. 2011. Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. Br J Pharmacol. 162(7):1650–1658.
   PubMed Web of Science ®Google Scholar
• Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. 2007. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology. 46(2):514–519.
   PubMed Web of Science ®Google Scholar
• Dadsetan S, Balzano T, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, Gil-Perotin S, Cubas-Nunez L, Garcia-Verdugo JM, Agusti A, et al. 2016. Reducing peripheral inflammation with infliximab reduces neuroinflammation and improves cognition in rats with hepatic encephalopathy. Front Mol Neurosci. 9:106.
   PubMed Web of Science ®Google Scholar
• Ding S, Zhuge W, Hu J, Yang J, Wang X, Wen F, Wang C, Zhuge Q. 2018. Baicalin reverses the impairment of synaptogenesis induced by dopamine burden via the stimulation of GABAAR-TrkB interaction in minimal hepatic encephalopathy. Psychopharmacology. 235(4):1163–1178.
   PubMed Web of Science ®Google Scholar
• Fromowitz FB, Viola MV, Chao S, Oravez S, Mishriki Y, Finkel G, Grimson R, Lundy J. 1987. ras p21 expression in the progression of breast cancer. Hum Pathol. 18(12):1268–1275.
   PubMed Web of Science ®Google Scholar
• Gorg B, Karababa A, Shafigullina A, Bidmon HJ, Haussinger D. 2015. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Glia. 63(1):37–50.
   PubMed Web of Science ®Google Scholar
• Hadjihambi A, Arias N, Sheikh M, Jalan R. 2018. Hepatic encephalopathy: a critical current review. Hepatol Int. 12(S1):135–147.
   PubMedGoogle Scholar
• Hernandez-Rabaza V, Cabrera-Pastor A, Taoro-Gonzalez L, Malaguarnera M, Agusti A, Llansola M, Felipo V. 2016. Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by sulforaphane. J Neuroinflammation. 13(1):41.
   PubMedGoogle Scholar
• Hol EM, Pekny M. 2015. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 32:121–130.
   PubMed Web of Science ®Google Scholar
• Hou XL, Tong Q, Wang WQ, Shi CY, Xiong W, Chen J, Liu X, Fang JG. 2015. Suppression of inflammatory responses by dihydromyricetin, a flavonoid from Ampelopsis grossedentata, via inhibiting the activation of NF-kappaB and MAPK signaling pathways. J Nat Prod. 78(7):1689–1696.
   PubMed Web of Science ®Google Scholar
• Jayakumar AR, Tong XY, Curtis KM, Ruiz-Cordero R, Abreu MT, Norenberg MD. 2014. Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. J Neurochem. 128(6):890–903.
   PubMed Web of Science ®Google Scholar
• Leke R, Bak LK, Iversen P, Sorensen M, Keiding S, Vilstrup H, Ott P, Portela LV, Schousboe A, Waagepetersen HS. 2011. Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy. J Neurochem. 117(5):824–832.
   PubMed Web of Science ®Google Scholar
• Li XQ, Dong L, Liu ZH, Luo JY. 2005. Expression of gamma-aminobutyric acid A receptor subunits alpha1, beta1, gamma2 mRNA in rats with hepatic encephalopathy. WJG. 11(21):3319–3322.
   PubMed Web of Science ®Google Scholar
• Ling H, Zhu Z, Yang J, He J, Yang S, Wu D, Feng S, Liao D. 2018. Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice. Acta Biochim Biophys Sin. 50(3):298–306.
   Google Scholar
• Liu D, Mao Y, Ding L, Zeng XA. 2019. Dihydromyricetin: a review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability. Trends Food Sci Technol. 91:586–597.
   PubMed Web of Science ®Google Scholar
• Liu TT, Zeng Y, Tang K, Chen X, Zhang W, Xu XL. 2017. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice. Atherosclerosis. 262:39–50.
   PubMed Web of Science ®Google Scholar
• Luo M, Guo JY, Cao WK. 2015. Inflammation: a novel target of current therapies for hepatic encephalopathy in liver cirrhosis. WJG. 21(41):11815–11824.
   PubMed Web of Science ®Google Scholar
• Parekh PJ, Balart LA. 2015. Ammonia and its role in the pathogenesis of hepatic encephalopathy. Clin Liver Dis. 19(3):529–537.
   PubMedGoogle Scholar
• Ren Z, Yan P, Zhu L, Yang H, Zhao Y, Kirby BP, Waddington JL, Zhen X. 2018. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation. Psychopharmacology. 235(1):233–244.
   PubMed Web of Science ®Google Scholar
• Sepehrinezhad A, Zarifkar A, Namvar G, Shahbazi A, Williams R. 2020. Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema. Metab Brain Dis. 35(4):559–578.
   PubMed Web of Science ®Google Scholar
• Song Q, Liu L, Yu J, Zhang J, Xu M, Sun L, Luo H, Feng Z, Meng G. 2017. Dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress. Eur J Pharmacol. 807:159–167.
   PubMed Web of Science ®Google Scholar
• Squires JE, McKiernan P, Squires RH. 2018. Acute liver failure: an update. Clin Liver Dis. 22(4):773–805.
   PubMed Web of Science ®Google Scholar
• Stahel PF, Shohami E, Younis FM, Kariya K, Otto VI, Lenzlinger PM, Grosjean MB, Eugster HP, Trentz O, Kossmann T, et al. 2000. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab. 20(2):369–380.
   PubMed Web of Science ®Google Scholar
• Stravitz RT, Lee WM. 2019. Acute liver failure. Lancet. 394(10201):869–881.
   PubMed Web of Science ®Google Scholar
• Wijdicks EF. 2016. Hepatic encephalopathy. N Engl J Med. 375(17):1660–1670.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Hua YQ, Wang W, Zhang H, Xu XL. 2020. Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin. Biochem Pharmacol. 175:113927.
   PubMed Web of Science ®Google Scholar
• Zhan G, Hua D, Huang N, Wang Y, Li S, Zhou Z, Yang N, Jiang R, Zhu B, Yang L, et al. 2019. Anesthesia and surgery induce cognitive dysfunction in elderly male mice: the role of gut microbiota. Aging. 11(6):1778–1790.
   PubMedGoogle Scholar
• Zhang J, Chen Y, Luo H, Sun L, Xu M, Yu J, Zhou Q, Meng G, Yang S. 2018. Recent update on the pharmacological effects and mechanisms of dihydromyricetin. Front Pharmacol. 9:1204.
   PubMed Web of Science ®Google Scholar